| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
361 |
| issn |
1535-2900
1079-2082 |
| issueIdentifier |
4 |
| pageRange |
358, 361-361 |
| publicationName |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |
| startingPage |
358, 361 |
| bibliographicCitation |
Valproate and carbamazepine join lithium as primary treatments for bipolar disorder. Am J Health Syst Pharm. 1995 Feb 15;52(4):358, 361. doi: 10.1093/ajhp/52.4.358. PMID: 7757856. |
| date |
1995-02-15^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/7757856
https://doi.org/10.1093/ajhp/52.4.358 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1079-2082
https://portal.issn.org/resource/ISSN/1535-2900
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8629 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Valproate and carbamazepine join lithium as primary treatments for bipolar disorder |
| discusses |
http://id.nlm.nih.gov/mesh/M0022501
http://id.nlm.nih.gov/mesh/M0012622
http://id.nlm.nih.gov/mesh/M0003328 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001714Q000628
http://id.nlm.nih.gov/mesh/D002220Q000627
http://id.nlm.nih.gov/mesh/D014635Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D004565
http://id.nlm.nih.gov/mesh/D008094Q000627
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3549980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760703 |